Jan 31, 2019
613:592
For every 592 shares held, investors received 613. The price per share adjusted from $107.15 to $103.48.
The split itself did not change the total investment value.
Krebs Biochemicals & Industries Ltd. (BSE:KREBSBIO) operates in the Pharmaceuticals: major industry.
Krebs Biochemicals & Industries Ltd. company overviewKrebs Biochemicals & Industries Ltd.'s most recent stock split was on January 31, 2019. It was a 613-for-592 forward split, so shareholders received 613 shares for every 592 they held.
Krebs Biochemicals & Industries Ltd. has split its stock once. This history records one forward split, on January 31, 2019.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Krebs Biochemicals & Industries Ltd.'s 613-for-592 split on January 31, 2019, every 592 shares became 613 shares.
Krebs Biochemicals & Industries Ltd. has not announced a new split in our records. Its most recent split was on January 31, 2019, 7 years ago. Companies announce splits in advance, and any new BSE:KREBSBIO split will appear on this page.
Already premium?